<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17324">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881359</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-LS-0146</org_study_id>
    <nct_id>NCT02881359</nct_id>
  </id_info>
  <brief_title>SEAL Registry - European Registry for the Effectiveness of LifeSeal® Kit</brief_title>
  <official_title>SEAL Registry - Observational, Retrospective and Prospective, One Arm, Registry Study for the Effectiveness of LifeSeal® Kit on Anastomotic Leaks in Patients Undergoing Low and Ultralow Anterior Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LifeBond Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LifeBond Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the effectiveness of commercially available LifeSeal® Kit as measured
      by the incidence of post-operative clinical anastomotic leak rates in subjects undergoing
      low and ultralow anterior resection with an anastomosis. All patients treated with LifeSeal®
      will be offered to participate
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The LifeSeal® Kit is a novel surgical sealant intended to be used as an adjunct to suture or
      staple line during standard surgical repair of the GI tract (anastomosis or linear) to
      provide re-inforcement and help reduce leaks. The LifeSeal™ Kit has recently been CE
      certified on March 2016 for marketing in the European Union.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>Incidence of post-operative clinical anastomotic leaks at discharge</measure>
    <time_frame>discharge from hospital 3-14 days post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of post-operative clinical anastomotic leaks up to 4 weeks post-surgery</measure>
    <time_frame>up to 4 weeks post surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anastomotic Leakage</condition>
  <arm_group>
    <arm_group_label>LifeSeal® Kit</arm_group_label>
    <description>creation of a coloanal or colorectal anastomosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LifeSeal® Kit</intervention_name>
    <description>used as an adjunct to suture or staple line during standard surgical repair of the GI tract (anastomosis or linear) to provide re-inforcement and help reduce leaks.</description>
    <arm_group_label>LifeSeal® Kit</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who are treated with LifeSeal® and comply with the eligibility criteria will
        be offered to participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ≥ 18 years of age at screening visit

          2. Written informed consent obtained

          3. Subject is scheduled to have or already underwent elective open, laparoscopic or
             robot assisted surgery involving the creation of a coloanal or colorectal
             anastomosis* created within 15 cm from the anal verge.

          4. Subject was already treated or is scheduled to be treated with LifeSeal® Kit, applied
             according to the IFU

        Exclusion Criteria:

        1. Subject with American Society of Anesthesiology (ASA) status &gt; 3.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Stoot, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zuyderland Medical Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sachi Norman, MD</last_name>
    <phone>+972 (0)4 6340816</phone>
    <phone_ext>816</phone_ext>
    <email>sachi@life-bond.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amit Korner, MPH</last_name>
    <phone>+49 1590 2477461</phone>
    <email>amit@life-bond.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jessa Ziekenhuis</name>
      <address>
        <city>Herselt</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bert Houben</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jan Yperman Ziekenhuis</name>
      <address>
        <city>Ieper</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lieven Dedrye</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AZ Delta</name>
      <address>
        <city>Roeselare</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul Pattyn</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZGT</name>
      <address>
        <city>Almelo</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Vanstiphout</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuyderland Medical Center</name>
      <address>
        <city>Sittard</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Stoot</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 20, 2016</lastchanged_date>
  <firstreceived_date>August 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anastomotic Leak</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
